BACKGROUND: The etiology of cardiovascular disease (CVD) is multifactorial. Efforts to identify genes influencing CVD risk have met with limited success to date, likely because of the small effect sizes of common CVD risk alleles and the presence of gene by gene and gene by environment interactions. METHODS: The HAPI Heart Study was initiated in 2002 to measure the cardiovascular response to 4 short-term interventions affecting cardiovascular risk factors and to identify the genetic and environmental determinants of these responses. The measurements included blood pressure responses to the cold pressor stress test and to a high salt diet, triglyceride excursion in response to a high-fat challenge, and response in platelet aggregation to aspirin therapy. RESULTS: The interventions were carried out in 868 relatively healthy Amish adults from large families. The heritabilities of selected response traits for each intervention ranged from 8% to 38%, suggesting that some of the variation associated with response to each intervention can be attributed to the additive effects of genes. CONCLUSIONS: Identifying these response genes may identify new mechanisms influencing CVD and may lead to individualized preventive strategies and improved early detection of high-risk individuals.
BACKGROUND: The etiology of cardiovascular disease (CVD) is multifactorial. Efforts to identify genes influencing CVD risk have met with limited success to date, likely because of the small effect sizes of common CVD risk alleles and the presence of gene by gene and gene by environment interactions. METHODS: The HAPI Heart Study was initiated in 2002 to measure the cardiovascular response to 4 short-term interventions affecting cardiovascular risk factors and to identify the genetic and environmental determinants of these responses. The measurements included blood pressure responses to the cold pressor stress test and to a high salt diet, triglyceride excursion in response to a high-fat challenge, and response in platelet aggregation to aspirin therapy. RESULTS: The interventions were carried out in 868 relatively healthy Amish adults from large families. The heritabilities of selected response traits for each intervention ranged from 8% to 38%, suggesting that some of the variation associated with response to each intervention can be attributed to the additive effects of genes. CONCLUSIONS: Identifying these response genes may identify new mechanisms influencing CVD and may lead to individualized preventive strategies and improved early detection of high-risk individuals.
Authors: W C Hsueh; B D Mitchell; J L Schneider; M J Wagner; C J Bell; E Nanthakumar; A R Shuldiner Journal: Circulation Date: 2000-06-20 Impact factor: 29.690
Authors: P F McArdle; J R O'Connell; T I Pollin; M Baumgarten; A R Shuldiner; P A Peyser; B D Mitchell Journal: Hum Hered Date: 2007-06-14 Impact factor: 0.444
Authors: Dina L Newman; Sabine Hoffjan; Catherine Bourgain; Mark Abney; Raluca I Nicolae; Elle T Profits; Michael A Grow; Karen Walker; Lori Steiner; Rodney Parry; Rebecca Reynolds; Mary Sara McPeek; Suzanne Cheng; Carole Ober Journal: Eur J Hum Genet Date: 2004-07 Impact factor: 4.246
Authors: Philip Greenland; Maria Deloria Knoll; Jeremiah Stamler; James D Neaton; Alan R Dyer; Daniel B Garside; Peter W Wilson Journal: JAMA Date: 2003-08-20 Impact factor: 56.272
Authors: Beth Wilmot; V Saroja Voruganti; Yen-Pei C Chang; Yi Fu; Zhan Chen; Herman A Taylor; James G Wilson; Teresa Gipson; Vallabh O Shah; Jason G Umans; Michael F Flessner; Robert Hitzemann; Alan R Shuldiner; Anthony G Comuzzie; Shannon McWeeney; Philip G Zager; Jean W Maccluer; Shelley A Cole; David M Cohen Journal: Physiol Genomics Date: 2011-12-20 Impact factor: 3.107
Authors: Katie L Nugent; Amber Million-Mrkva; Joshua Backman; Sarah H Stephens; Robert M Reed; Peter Kochunov; Toni I Pollin; Alan R Shuldiner; Braxton D Mitchell; L Elliot Hong Journal: Nicotine Tob Res Date: 2014-02-28 Impact factor: 4.244
Authors: Toni I Pollin; Coleen M Damcott; Haiqing Shen; Sandra H Ott; John Shelton; Richard B Horenstein; Wendy Post; John C McLenithan; Lawrence F Bielak; Patricia A Peyser; Braxton D Mitchell; Michael Miller; Jeffrey R O'Connell; Alan R Shuldiner Journal: Science Date: 2008-12-12 Impact factor: 47.728
Authors: Richard B Horenstein; Braxton D Mitchell; Wendy S Post; Dieter Lütjohann; Klaus von Bergmann; Kathleen A Ryan; Michael Terrin; Alan R Shuldiner; Nanette I Steinle Journal: Arterioscler Thromb Vasc Biol Date: 2012-12-13 Impact factor: 8.311
Authors: Woei-Jyh Lee; Toni I Pollin; Jeffrey R O'Connell; Richa Agarwala; Alejandro A Schäffer Journal: BMC Med Genet Date: 2010-05-02 Impact factor: 2.103
Authors: Lawrence F Bielak; Richard B Horenstein; Kathleen A Ryan; Patrick F Sheedy; John A Rumberger; Keith Tanner; Wendy Post; Braxton D Mitchell; Alan R Shuldiner; Patricia A Peyser Journal: Clin Med Cardiol Date: 2009-05-27
Authors: Cristopher V Van Hout; Albert M Levin; Evadnie Rampersaud; Haiqing Shen; Jeffrey R O'Connell; Braxton D Mitchell; Alan R Shuldiner; Julie A Douglas Journal: Genet Epidemiol Date: 2010-02 Impact factor: 2.135